Life Science CompanyGENEWEL

Based on “The Right, The Best”

We Achieve a Healthy and Pleasurable Lives
Through Leading Life Science Solutions

GENEWEL

Genewel stands out in the domestic biomaterial field, evolving into a global life
science company dedicated to creating healthy happiness through life science
solutions.

We develop next-generation, customer-centered innovative technologies to
enhance the quality of life with dependable quality.

Genewel envisions a healthy and vibrant tomorrow for everyone, building a better
future through continuous innovation

  • C.E.OSang-Deok Han
  • Established 0n 2000.7.21.
  • Major ProductsWound dressing, anti-adhesives
  • Main Phone +82-31-8018-5500
  • Business Sites
    • Main Office. 37 62-gil, Sagimakgol-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do
      (5/6th fl., STAR TOWER, Sangdaewon-dong)
    • Hwasung . 281-2, Soltaesangdu-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do, Korea
View LocationDownload CI

PRODUCT INFORMATION

Healthcare

Biomaterial Medical Devices

Consumer

Cosmetics Materials

Financial Status

Balance Sheet Unit : million KRW

Genewel 2023year Financial Status Table
FY 2021Y FY 2022Y FY 2023Y
Total Assets 38,149 42,260 43,533
Current assets 24,094 26,157 27,624
Non-current assets 14,055 16,102 15,909
Total Liabilities 8,224 7,492 5,258
Current liabilities 6,632 6,754 4,708
Non-current liabilities 1,592 737 551
Total Assets 29,926 34,768 38,275

Income Statement Unit : million KRW

Genewel 2023year Income Statement
FY 2021Y FY 2022Y FY 2023Y
Revenue 30,321 32,496 32,524
Operating profit 7,885 9,279 7,650
Net profit 6,102 7,762 6,827
Announcement